The move towards telemedicine as part of diabetes care has been accelerated as a consequence of the COVID-19 pandemic.

Remote glucose-sensing technologies have enabled effective glucose control for adults and children with type 1 diabetes mellitus that is not inferior to standard care pre-COVID.

Evidence shows that adults and children with diabetes are able to engage with their healthcare professional via telemonitoring and receive significant healthcare-related quality of life benefits.

Telemedicine and telemonitoring can improve patient autonomy to manage their diabetes.

Healthcare systems across Europe should support sustainable and broad access to continuous glucose monitoring systems and the remote monitoring solutions associated with them.

Challenges for eHeath include: patient privacy and data ownership; cybersecurity; access to and interoperability of eHealth technologies; incentivisation for providers and health systems; and legal and commercial frameworks specific to eHealth that serve to protect all stakeholders in eHealth.